Corpusense

Medtronic (MDT) earnings call transcript summary & sentiment

Last call Tue 1 Sep 2026

Our read on the 1 September 2026 earnings call

Overall tone: Positive

Overall tone

Positive

Executive Summary

Medtronic delivered strong financial results in Q1 FY27, reporting $9.8 billion in revenue (up 13.7% reported and organic) and adjusted EPS of $1.45, exceeding internal expectations and street estimates.

Core Signals

Revenue Growth & Demand: First-quarter organic revenue grew 13.7% to $9.8 billion, driven by 16% US growth and 12% international growth, backed by broad procedure demand.

Bullish Signals

Cardiac Ablation Solutions delivered 88% global growth and passed $2 billion in trailing 12-month revenue.

Risk Signals

An extra selling week added $570 million or 670 basis points to Q1 organic revenue growth, setting up tougher comparisons ahead.

Q&A Signals

Repeated analyst topics: Analysts repeatedly questioned the rationale and portfolio impact of the $700 million investment in Cornerstone Robotics relative to Hugo.

Key Investor Debate

The primary debate among investors centers on Medtronic's surgical robotics strategy following its strategic investment in Cornerstone Robotics.

Analyst Takeaway

Medtronic is displaying clear top-line momentum across core cardiovascular and surgical platforms while maintaining pricing discipline and manufacturing efficiency.

Those are the opening lines. The full read covers the whole earnings transcript: every bullish and bearish signal, what analysts pressed hardest on, and where management answered vaguely — each with the quote behind it. Every line sourced.

See the full Earnings Highlight

Themes across Medtronic and the Health Care sector

Analyse a theme over quarters — what's brand new, what's being talked about more, and what is spreading to more companies across the sector.

Unlock themes

Ask about Medtronic's earnings, or other S&P 500 earnings calls

Ask across the corpus, instead of reading one call at a time. Scope it to Medtronic, its sector, or every name we cover — plain English, no operators — and answers come back structured: a summary, the drivers, and a read on each company.

"What did Medtronic say about margins, and did the framing change from last quarter?"

"Did Medtronic's management walk back any full-year guidance, and how did they frame it?"

"Where did Medtronic avoid answering on capital allocation?"

Unlock search

Earnings call history & sentiment

Date Day Period Corpusense read
2026-09-01Tuesday2026 Q3Positive
2026-06-03Wednesday2026 Q2Positive
2026-02-17Tuesday2026 Q1Positive
2025-11-18Tuesday2025 Q4—
2025-08-19Tuesday2025 Q3—
2025-05-21Wednesday2025 Q2—
2025-02-18Tuesday2025 Q1—

Earnings calls across Health Care Equipment & Supplies

The companies Medtronic is read alongside. Each has its own earnings call dates and sentiment.

ABTAbbott LaboratoriesALGNAlign TechnologyBAXBaxter InternationalBDXBecton DickinsonBSXBoston ScientificCOOCooper Companies (The)DXCMDexcomEWEdwards Lifesciences

Medtronic is one of the S&P 500 companies we track

Sentiment analysis on any single earnings call, themes building across a sector, and search across every company and quarter — each claim linked back to the passage it came from.

Create a free account See the full calendar Plans & pricing